Home / Countries / Poland / HIV medicines

Poland · availability and reimbursement

HIV medicines in Poland

Of 35 verified HIV medicine records for Poland, 30 are available and reimbursed (86%), 3 are available but not reimbursed and 2 are not available. 7 further records are still under review.

86% of verified records reimbursed

Last checked 14/09/2026 · This is information only, not advice or a recommendation.

Medicines by status

Available and reimbursed 30

Biktarvy, Celsentri, Delstrigo, Descovy, Dovato, Edurant, Emtriva, Epivir, Eviplera, Genvoya, Intelence, Isentress, Juluca, Kaletra, Kivexa, Norvir, Odefsey, Pifeltro, Prezista, Rekambys, Retrovir, Rezolsta, Stribild, Symtuza, Tivicay, Triumeq, Truvada, Viread, Vocabria, Ziagen

Available, not reimbursed 3

Generic TDF/FTC (Emtricitabine/Tenofovir DF), Rukobia, Sunlenca

Not available 2

Generic TLD (Tenofovir/Lamivudine/Dolutegravir), Generic TLE (Tenofovir/Lamivudine/Efavirenz)

Under review 7

Apretude, Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, Emtricitabine / Tenofovir alafenamide Viatris, Evotaz, Reyataz, Vocabria / Rekambys, Yeytuo

See every medicine with its source →

More about Poland

PrEPDoxyPEPSexuality educationAbortion and contraceptionMigrant healthcareFull Poland profile

Neighbouring countries

UkraineSlovakiaRussian FederationLithuaniaGermanyCzechiaBelarus

Open the interactive map

Based on public, cited sources and SHAPE's review. Rules and prices change, so please confirm with the national authority or a professional. Found an error? Tell us.